This Article  • References  • Full text PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

William H. Oldendorf, MD

Arch Neurol. 1973;28(1):45-48.

Abstract
Thirteen amino acids labeled with 14C were rapidly injected individually into rat common carotid artery along with tritiated water as a diffusable reference substance. All amino acid brain uptakes studied were reduced by a control serum vehicle pooled from nonphenylketonuric (PKU) retardeds, relative to a vehicle of buffered Ringer's solution. Two vehicles, sera pooled from phenylketonurics and a control serum vehicle to which unlabeled phenylalanine had been added and thus reconstituted to bring the serum phenylalanine level up to that of the PKU serum, each caused a significant reduction of large neutral amino acid uptakes but had an insignificant effect on basic amino acids. Saturation of the large neutral amino acid blood brain barrier transport system may result in a brain deprivation in infancy of those amino acids using the same carrier transport system as phenylalanine and thus be causally related to mental retardation in PKU.

Author Affiliations
Los Angeles

From the research and neurology services, Veterans Administration, Wadsworth Hospital Center, and the Reed Neurological Research Center, Department of Neurology, University of California-Los Angeles School of Medicine, Los Angeles.

Footnotes
Accepted for publication Aug 17, 1972.

Reprint requests to Veterans Administration, Wadsworth Hospital Center, Wilshire and Sawtelle Boulevards, Los Angeles 90073 (Dr. Oldendorf).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Neurologic and Psychiatric Manifestations in a Family With a Mutation in Exon 2 of the Guanosine Triphosphate-Cyclohydrolase Gene
Hahn et al.
Arch Neurol 2001;58:749-755.
ABSTRACT | FULL TEXT  

Randomised controlled trial of tyrosine supplementation on neuropsychological performance in phenylketonuria
Smith et al.
Arch. Dis. Child. 1998;78:116-121.
ABSTRACT | FULL TEXT  

Cerebrospinal Fluid as a Reflector of Central Cholinergic and Amino Acid Neurotransmitter Activity in Cerebellar Ataxia
Manyam et al.
Arch Neurol 1990;47:1194-1199.
ABSTRACT  

Valine, Isoleucine, and Leucine: A New Treatment for Phenylketonuria
Berry et al.
Arch Pediatr Adolesc Med 1990;144:539-543.
ABSTRACT  

Biogenic amine synthesis defect in dihydropteridine reductase deficiency
Koslow and Butler
Science 1977;198:522-523.
ABSTRACT  

Lowering Brain Phenylalanine Levels by Giving Other Large Neutral Amino Acids: A New Experimental Therapeutic Approach to Phenylketonuria
Andersen and Avins
Arch Neurol 1976;33:684-686.
ABSTRACT